Drug Profile
3-BAABU
Alternative Names: 3-bromoacetylamino benzoylurea; MF 191Latest Information Update: 29 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Apoptosis stimulants; Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 10 Nov 1998 New profile
- 10 Nov 1998 Preclinical development for Cancer in USA (Unknown route)